Phospholipase D1 mediates TNFα-induced inflammation in a murine model of TNFα-induced peritonitis

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Sethu, Swaminathan ^a   Pushparaj, Peter N ^b   Melendez, Alirio J ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; INTERLEUKIN 6; PHOSPHOLIPASE D1; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FUNCTIONAL GENOMICS; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PERITONITIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BODY TEMPERATURE; CAPILLARY PERMEABILITY; CELL ADHESION MOLECULES; CHEMOKINES; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; INFLAMMATION; MALE; MICE; MICE, INBRED BALB C; MONOCYTES; NEUTROPHIL INFILTRATION; PERITONEUM; PERITONITIS; PHOSPHOLIPASE D; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS;

EID: 77956412548     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010506     Document Type: Article

References (54)

1. Tracey KJ, Cerami A (1994) Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45: 491-503.
2. Tracey KJ, Cerami A (1993) Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9: 317-343.
3. Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11: 372-377.
4. Chen G, Goeddel DV (2002) TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635.
5. MacEwan DJ (2002) TNF ligands and receptors-a matter of life and death. Br J Pharmacol 135: 855-875.
6. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a doubleedged sword. Nat Rev Immunol 3: 745-756.
7. Lin J, Ziring D, Desai S, Kim S, Wong M, et al. (2008) TNFalpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol 126: 13-30.
8. Wong M, Ziring D, Korin Y, Desai S, Kim S, et al. (2008) TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol 126: 121-136.
9. Hehlgans T, Mannel DN (2002) The TNF-TNF receptor system. Biol Chem 383: 1581-1585.
10. Sethu S, Mendez-Corao G, Melendez AJ (2008) Phospholipase D1 plays a key role in TNF-alpha signaling. J Immunol 180: 6027-6034.
11. Heller M (1978) Phospholipase D. Adv Lipid Res 16: 267-326.
12. Yang SF, Freer S, Benson AA (1967) Transphosphatidylation by phospholipase D. J Biol Chem 242: 477-484.
13. Sciorra VA, Morris AJ (1999) Sequential actions of phospholipase D and phosphatidic acid phosphohydrolase 2b generate diglyceride in mammalian cells. Mol Biol Cell 10: 3863-3876.
14. English D, Cui Y, Siddiqui RA (1996) Messenger functions of phosphatidic acid. Chem Phys Lipids 80: 117-132.
15. English D (1996) Phosphatidic acid: a lipid messenger involved in intracellular and extracellular signalling. Cell Signal 8: 341-347.
16. Exton JH (2002) Regulation of phospholipase D. FEBS Lett 531: 58-61.
17. Exton JH (2002) Phospholipase D-structure, regulation and function. Rev Physiol Biochem Pharmacol 144: 1-94.
18. Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, et al. (1997) Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol 7: 191-201.
19. Siddhanta A, Shields D (1998) Secretory vesicle budding from the trans-Golgi network is mediated by phosphatidic acid levels. J Biol Chem 273: 17995-17998.
20. Kusner DJ, Hall CF, Jackson S (1999) Fc gamma receptor-mediated activation of phospholipase D regulates macrophage phagocytosis of IgG-opsonized particles. J Immunol 162: 2266-2274.
21. Gewirtz AT, Simons ER (1997) Phospholipase D mediates Fc gamma receptor activation of neutrophils and provides specificity between high-valency immune complexes and fMLP signaling pathways. J Leukoc Biol 61: 522-528.
22. Dana RR, Eigsti C, Holmes KL, Leto TL (2000) A regulatory role for ADPribosylation factor 6 (ARF6) in activation of the phagocyte NADPH oxidase. J Biol Chem 275: 32566-32571.
23. Melendez AJ, Bruetschy L, Floto RA, Harnett MM, Allen JM (2001) Functional coupling of FcgammaRI to nicotinamide adenine dinucleotide phosphate (reduced form) oxidative burst and immune complex trafficking requires the activation of phospholipase D1. Blood 98: 3421-3428.
24. Lehman N, Di Fulvio M, McCray N, Campos I, Tabatabaian F, Gomez-Cambronero J (2006) Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2. Blood 108: 3564-3572.
25. Atta ur R, Harvey K, Siddiqui RA (1999) Interleukin-8: An autocrine inflammatory mediator. Curr Pharm Des 5: 241-253.
26. Hammond SM, Altshuller YM, Sung TC, Rudge SA, Rose K, et al. (1995) Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J Biol Chem 270: 29640-29643.
27. Morgan CP, Sengelov H, Whatmore J, Borregaard N, Cockcroft S (1997) ADPribosylation- factor-regulated phospholipase D activity localizes to secretory vesicles and mobilizes to the plasma membrane following N-formylmethionylleucyl- phenylalanine stimulation of human neutrophils. Biochem J 325: 581-585.
28. Singh N, Seki Y, Takami M, Baban B, Chandler PR, et al. (2006) Enrichment of regulatory CD4(+)CD25(+) T cells by inhibition of phospholipase D signaling. Nat Methods 3: 629-636.
29. Locati M, Riboldi E, Bonecchi R, Transidico P, Bernasconi S, et al. (2001) Selective induction of phospholipase D1 in pathogen-activated human monocytes. Biochem J 358: 119-125.
30. Iyer SS, Agrawal RS, Thompson CR, Thompson S, Barton JA, Kusner DJ (2006) Phospholipase D1 regulates phagocyte adhesion. J Immunol 176: 3686-3696.
31. Cadwallader KA, Uddin M, Condliffe AM, Cowburn AS, White JF, et al. (2004) Effect of priming on activation and localization of phospholipase D-1 in human neutrophils. Eur J Biochem 271: 2755-2764.
32. Hamdi SM, Cariven C, Coronas S, Malet N, Chap H, et al. (2008) Potential role of phospholipase D2 in increasing interleukin-2 production by T-lymphocytes through activation of mitogen-activated protein kinases ERK1/ERK2. Biochim Biophys Acta 1781: 263-269.
33. Mor A, Campi G, Du G, Zheng Y, Foster DA, et al. (2007) The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2. Nat Cell Biol 9: 713-719.
34. Pushparaj PN, H'Ng SC, Melendez AJ (2008) Refining siRNA in vivo transfection: silencing SPHK1 reveals its key role in C5a-induced inflammation in vivo. Int J Biochem Cell Biol 40: 1817-1825.
35. Kim H, Lee J, Kim S, Shin MK, Min do S, Shin T (2007) Differential expression of phospholipases D1 and D2 in mouse tissues. Cell Biol Int 31: 148-155.
36. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, et al. (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467.
37. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168: 4620-4627.
38. Wallis RS, Broder M, Wong J, Lee A, Hoq L (2005) Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis 41 Suppl 3: S194-198.
39. Van Hensbroek MB, Palmer A, Onyiorah E, Schneider G, Jaffar S, et al. (1996) The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 174: 1091-1097.
40. Zanetti G, Heumann D, Gerain J, Kohler J, Abbet P, et al. (1992) Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factoralpha and to lipopolysaccharide. J Immunol 148: 1890-1897.
41. Sundgren-Andersson AK, Ostlund P, Bartfai T (1998) IL-6 is essential in TNFalpha- induced fever. Am J Physiol 275: R2028-2034.
42. Kamimura D, Ishihara K, Hirano T (2003) IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 149: 1-38.
43. Kishimoto T (2006) Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 8 Suppl 2: S2.
44. Holtkamp W, Stollberg T, Reis HE (1995) Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease. J Clin Gastroenterol 20: 123-126.
45. Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, et al. (2001) Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 125: 177-183.
46. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, et al. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83-85.
47. Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, et al. (1988) Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18: 1797-1801.
48. Stuart RA, Littlewood AJ, Maddison PJ, Hall ND (1995) Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders. Clin Exp Rheumatol 13: 17-22.
49. Grisius MM, Bermudez DK, Fox PC (1997) Salivary and serum interleukin 6 in primary Sjogren's syndrome. J Rheumatol 24: 1089-1091.
50. Maurer M, von Stebut E (2004) Macrophage inflammatory protein-1. Int J Biochem Cell Biol 36: 1882-1886.
51. Murdoch C, Finn A (2000) Chemokine receptors and their role in inflammation and infectious diseases. Blood 95: 3032-3043.
52. Matsumoto K, Kanmatsuse K (1999) Increased IL-12 release by monocytes in nephritic patients. Clin Exp Immunol 117: 361-367.
53. DeVries ME, Ran L, Kelvin DJ (1999) On the edge: the physiological and pathophysiological role of chemokines during inflammatory and immunological responses. Semin Immunol 11: 95-104.
54. Hill GR, Teshima T, Gerbitz A, Pan L, Cooke KR, et al. (1999) Differential roles of IL-1 and TNF-a on graft-versus-host disease and graft versus leukemia. J Clin Invest 104: 459-467.